Cantor Fitzgerald Downgrades Longboard Pharmaceuticals to Neutral

Benzinga · 10/14 15:14
Cantor Fitzgerald analyst Josh Schimmer downgrades Longboard Pharmaceuticals (NASDAQ:LBPH) from Overweight to Neutral.